
zzso and the use of zzso were investigated in patients with chronic cancer pain treated with oral zzso and zzso zzso in an open sequential zzso zzso patients were treated with zzso zzso zzso zzso for 6 days and 39 of these patients were switched to zzso zzso zzso zzso with a conversion ratio of zzso Median zzso doses increased from zzso to zzso zzso throughout the 30-day zzso treatment zzso zzso patients completed the zzso Two patients died from the basic disease while treated with zzso zzso 12 patients were excluded for various reasons, and not enough data for evaluation were available for two zzso Mean pain intensity decreased slightly after conversion although the number of patients with breakthrough pain or requiring zzso zzso as a rescue medication was higher with zzso zzso The number of patients with zzso movements did not change after the zzso switch but the number of patients taking zzso was reduced significantly from zzso of the patients per treatment day zzso to zzso zzso zzso was used mainly and was reduced most drastically, but other zzso were also used less zzso In this study zzso zzso was associated with a significantly lower use of zzso compared to oral zzso The difference in the degree of zzso between the two zzso regimens should be confirmed in a zzso zzso study that takes into account both zzso and use of zzso 

